Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Dasatinib/Imatinib

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nakamura Y, et al. Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib. Geriatrics and Gerontology International 23 : 965-966, No. 12, Dec 2023. Available from: URL: https://dx.doi.org/10.1111/ggi.14713 Nakamura Y, et al. Analysis of drug transporter gene polymorphisms in an elderly patient with chronic myeloid leukemia successfully treated with intermittent low-dose dasatinib. Geriatrics and Gerontology International 23 : 965-966, No. 12, Dec 2023. Available from: URL: https://​dx.​doi.​org/​10.​1111/​ggi.​14713
Metadaten
Titel
Dasatinib/Imatinib
Various toxicities
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57388-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Idelalisib